Ataxia with vitamin E deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:96OMIM:277460G11.1
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ataxia with vitamin E deficiency (AVED), also known as familial isolated vitamin E deficiency or ataxia with isolated vitamin E deficiency, is a rare inherited neurodegenerative disorder caused by mutations in the TTPA gene (alpha-tocopherol transfer protein gene) on chromosome 8q12. This gene encodes the alpha-tocopherol transfer protein, which is essential for incorporating vitamin E (alpha-tocopherol) into very low-density lipoproteins in the liver for distribution throughout the body. When this protein is deficient or dysfunctional, vitamin E levels in the blood become severely reduced, leading to progressive neurological damage. The disease primarily affects the nervous system, particularly the cerebellum and peripheral nerves. The clinical presentation closely resembles Friedreich ataxia and typically begins in childhood or adolescence, usually between ages 5 and 15. Key features include progressive cerebellar ataxia (difficulty coordinating movements), dysarthria (slurred speech), loss of proprioception (position sense), areflexia (absent deep tendon reflexes), and a positive Babinski sign. Some patients may also develop retinitis pigmentosa leading to visual impairment, cardiomyopathy, scoliosis, and head titubation. Without treatment, the disease is progressively disabling. AVED is one of the few treatable hereditary ataxias. Early and lifelong oral supplementation with high-dose vitamin E (typically 800–1200 mg/day of alpha-tocopherol) can halt disease progression and, in some cases, partially reverse neurological symptoms, particularly if treatment is initiated before significant irreversible damage has occurred. Serum vitamin E levels should be monitored regularly to ensure adequate supplementation. The prognosis is significantly improved with early diagnosis and consistent treatment, underscoring the importance of measuring serum vitamin E levels in any patient presenting with progressive ataxia, especially when Friedreich ataxia has been excluded.

Also known as:

Clinical phenotype terms— hover any for plain English:

Decreased circulating vitamin E concentrationHP:0100513Head titubationHP:0002599
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ataxia with vitamin E deficiency.

View clinical trials →

No actively recruiting trials found for Ataxia with vitamin E deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ataxia with vitamin E deficiency community →

Specialists

1 foundView all specialists →
LS
Laurent Servais
Specialist
PI on 1 active trial28 Ataxia with vitamin E deficiency publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ataxia with vitamin E deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ataxia with vitamin E deficiencyForum →

No community posts yet. Be the first to share your experience with Ataxia with vitamin E deficiency.

Start the conversation →

Latest news about Ataxia with vitamin E deficiency

No recent news articles for Ataxia with vitamin E deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ataxia with vitamin E deficiency

What is Ataxia with vitamin E deficiency?

Ataxia with vitamin E deficiency (AVED), also known as familial isolated vitamin E deficiency or ataxia with isolated vitamin E deficiency, is a rare inherited neurodegenerative disorder caused by mutations in the TTPA gene (alpha-tocopherol transfer protein gene) on chromosome 8q12. This gene encodes the alpha-tocopherol transfer protein, which is essential for incorporating vitamin E (alpha-tocopherol) into very low-density lipoproteins in the liver for distribution throughout the body. When this protein is deficient or dysfunctional, vitamin E levels in the blood become severely reduced, le

How is Ataxia with vitamin E deficiency inherited?

Ataxia with vitamin E deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ataxia with vitamin E deficiency typically begin?

Typical onset of Ataxia with vitamin E deficiency is childhood. Age of onset can vary across affected individuals.

Which specialists treat Ataxia with vitamin E deficiency?

1 specialists and care centers treating Ataxia with vitamin E deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.